Envita's AAIT - a Powerful Immunotherapy for Cancer


Published on

http://www.envita.com/conditions-we-treat/cancer/immunotherapy/ - Immunotherapy for Cancer Treatment is absolutely necessary, and many are lacking it. At Envita, it is not an afterthought but in fact, our focus. The immune system is the first and last defense against cancer, and we believe to be critical for long-term success.

Published in: Health & Medicine
  • Be the first to comment

  • Be the first to like this

No Downloads
Total views
On SlideShare
From Embeds
Number of Embeds
Embeds 0
No embeds

No notes for slide

Envita's AAIT - a Powerful Immunotherapy for Cancer

  1. 1. Envitas AAIT - a Powerful Immunotherapy for CancerAAIT is an acronym for autologous adoptive immune therapy and describes a therapyderived from the patient’s own blood, and is re-infused during treatment. There aremyriad strategies for immunotherapy and just as many treatments that fall under theheading “autologous adoptive immunotherapy.” That being said – not all options arecomparable.Enivtas immunotherapy, AAIT, involves 4 major cell types including: • Natural killer cells • Natural killer T cells • Cytokine-induced killer cells • Cytotoxic T lymphocytesThe inclusion of Natural killer cells (NKs) and Natural killer T cells (NKTs) are theprimary focus of Envita’s AAIT immunotherapy serums.Keys to Envitas AAIT Uniqueness1) Envitas protocol for AAIT is designed to optimize the expansion of natural killer cells -the most potent cancer fighting component of the cellular immune system. Most immunetherapies do include natural killer cells, and those that do only expand them in lownumbers with little activation.2) Envitas AAIT protocol takes only 4-5 weeks to grow your cells, so you can begin toexperience benefits quickly. Moreover, while other immune therapies administer just100-200 million cells per treatment, Envita delivers roughly 100 times as many duringthe course of your treatment.
  2. 2. 3) Multitudes of published studies demonstrate the effects of adoptive immune therapyin cancer patients for which Envita has identified and improved upon the best. Companyprotocol insists upon the highest-level of procedure for the expansion and application ofcells for each immunotherapy treatment.4) Unlike other published immune therapies, Envitas AAIT is the only one that can beused as a “stand-alone.” Moreover, it may also be administered in conjunction with othertherapies to enhance the cells’ effects in patients – an incomparable benefit. EnvitasAAIT therapy is not focused solely on expanding cells in the lab; rather, our goal alsoincludes keeping them active until reintroduced to the patient’s body.5) Envita’s AAIT offers far greater tumor kill, or cytotoxicity than that of other well-regarded cancer cell vaccines / immunotherapies found throughout the world. In brief,this means Envita’s activated natural killer cells in AAIT deliver considerably highertumor obliteration.6) In summary, the most direct manner to stack Envita’s proprietary immunotherapyagainst the others, includes its: a. Quality - based on cytoxicity (how much tumor the immune system can kill). Envita’s AAIT immunotherapy consistently delivers “significantly greater tumor kill”. b. Quantity (how many cells you get back) – Envita’s AAIT immunotherapy comes with 100 times the cell dosage than the others. c. Sterility (quality control measures) – Envita AAIT immunotherapy is completely contaminant free.If you have any questions concerning Envitas AAIT immunotherapy, please consult withEnvitas team of physicians and patient educators. This immunotherapy is offered atEnvita’s international cancer center in Mexico.